Bauer E A, Kronberger A, Stricklin G P, Smith L T, Holbrook K A
Exp Cell Res. 1985 Dec;161(2):484-94. doi: 10.1016/0014-4827(85)90103-x.
Since skin collagenase is required for initiation of the degradation of types I and III collagens, the major collagens of the human dermis, we examined its expression during embryonic and fetal development. When using skin fibroblasts cultured from human embryos and fetuses, immunoreactive collagenase concentrations were strongly correlated with estimated gestational age (p less than 0.001), with levels at 7-8 weeks of gestation that were about one-twentieth of those in the 29-week cell cultures. In crude culture medium, the apparent catalytic efficiency (activity per unit immunoreactive protein) was variable, an observation attributable in part to variable expression of a collagenase-inhibitory protein. Following chromatographic purification, four of ten fetal collagenases were found to have greater than or equal to 4-fold decrease in specific activity, suggesting that these particular fetal collagenases may be structurally and/or catalytically altered. Since the decreased levels of immunoreactive protein suggested that decreased enzyme synthesis was the major mechanism, we examined collagenase synthesis in a cell-free translation system. Here, we quantitated collagenase expression in the culture medium of intact cells prior to harvesting mRNA. Compared with the intact adult cells, the fetal cells had 3-17 times less collagenase activity in the medium, while in cell-free translation there was a 2- to 3-fold decrease in collagenase synthesis. These data suggest that decreased in vitro expression is correlated with decreased levels of translatable collagenase mRNA but that other factors, such as the collagenase inhibitor and altered specific activity of the enzyme, may be important in modulating collagenase activity.
由于皮肤胶原酶是启动人体真皮中主要的I型和III型胶原蛋白降解所必需的,因此我们研究了其在胚胎和胎儿发育过程中的表达。当使用从人类胚胎和胎儿培养的皮肤成纤维细胞时,免疫反应性胶原酶浓度与估计的胎龄密切相关(p小于0.001),妊娠7-8周时的水平约为29周细胞培养物中的二十分之一。在粗培养基中,表观催化效率(每单位免疫反应性蛋白的活性)是可变的,这一观察结果部分归因于胶原酶抑制蛋白的可变表达。经过色谱纯化后,发现十种胎儿胶原酶中有四种的比活性下降了4倍或更多,这表明这些特定的胎儿胶原酶在结构和/或催化方面可能发生了改变。由于免疫反应性蛋白水平的降低表明酶合成减少是主要机制,我们在无细胞翻译系统中研究了胶原酶的合成。在这里,我们在收获mRNA之前定量了完整细胞培养基中胶原酶的表达。与完整的成年细胞相比,胎儿细胞培养基中的胶原酶活性低3-17倍,而在无细胞翻译中,胶原酶合成下降了2至3倍。这些数据表明,体外表达的降低与可翻译的胶原酶mRNA水平的降低相关,但其他因素,如胶原酶抑制剂和酶的特定活性改变,可能在调节胶原酶活性方面很重要。